345 related articles for article (PubMed ID: 15195211)
21. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.
Obritsch MD; Fish DN; MacLaren R; Jung R
Antimicrob Agents Chemother; 2004 Dec; 48(12):4606-10. PubMed ID: 15561832
[TBL] [Abstract][Full Text] [Related]
22. [Antimicrobial susceptibility of Pseudomonas aeruginosa clinical isolates in Castellón, Spain].
Gomila Sard B; Pardo Serrano FJ; Moreno Muñoz R; Celades Porcar E; García del Busto Remón A
Rev Esp Quimioter; 2006 Mar; 19(1):60-4. PubMed ID: 16688293
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.
Walkty A; Decorby M; Nichol K; Mulvey MR; Hoban D; Zhanel G;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):217-21. PubMed ID: 18304774
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.
Gales AC; Jones RN; Turnidge J; Rennie R; Ramphal R
Clin Infect Dis; 2001 May; 32 Suppl 2():S146-55. PubMed ID: 11320454
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
Rhomberg PR; Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
[TBL] [Abstract][Full Text] [Related]
26. Ciprofloxacin-resistant Pseudomonas keratitis.
Garg P; Sharma S; Rao GN
Ophthalmology; 1999 Jul; 106(7):1319-23. PubMed ID: 10406614
[TBL] [Abstract][Full Text] [Related]
27. Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.
Sasaki M; Hiyama E; Takesue Y; Kodaira M; Sueda T; Yokoyama T
J Hosp Infect; 2004 Feb; 56(2):111-8. PubMed ID: 15019222
[TBL] [Abstract][Full Text] [Related]
28. Efflux pump genes and antimicrobial resistance of Pseudomonas aeruginosa strains isolated from lower respiratory tract infections acquired in an intensive care unit.
Ozer B; Duran N; Onlen Y; Savas L
J Antibiot (Tokyo); 2012 Jan; 65(1):9-13. PubMed ID: 22086166
[TBL] [Abstract][Full Text] [Related]
29. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
[TBL] [Abstract][Full Text] [Related]
30. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia].
Abdallah HB; Noomen S; Khélifa AB; Sahnoun O; Elargoubi A; Mastouri M
Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Pseudomonas aeruginosa strains isolated from burned patients hospitalized in a major burn center in Tehran, Iran.
Ranjbar R; Owlia P; Saderi H; Mansouri S; Jonaidi-Jafari N; Izadi M; Farshad S; Arjomandzadegan M
Acta Med Iran; 2011; 49(10):675-9. PubMed ID: 22071644
[TBL] [Abstract][Full Text] [Related]
32. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
Bennett KM; Scarborough JE; Sharpe M; Dodds-Ashley E; Kaye KS; Hayward TZ; Vaslef SN
J Trauma; 2007 Aug; 63(2):307-11. PubMed ID: 17693828
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units.
Vojtová V; Kolár M; Hricová K; Uvízl R; Neiser J; Blahut L; Urbánek K
New Microbiol; 2011 Jul; 34(3):291-8. PubMed ID: 21811750
[TBL] [Abstract][Full Text] [Related]
34. [Infectivity and resistance to antibiotics of bacterial strains isolated from patients hospitalised in intensive care units].
Wojnicz D; Korzekwa K; Kakol A; Doroszkiewicz W
Med Dosw Mikrobiol; 2007; 59(1):75-84. PubMed ID: 17601034
[TBL] [Abstract][Full Text] [Related]
35. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug-resistant Pseudomonas aeruginosa.
Oie S; Uematsu T; Sawa A; Mizuno H; Tomita M; Ishida S; Okano Y; Kamiya A
J Antimicrob Chemother; 2003 Dec; 52(6):911-4. PubMed ID: 14585851
[TBL] [Abstract][Full Text] [Related]
36. [Evolution of antimicrobial resistance against Pseudomonas aeruginosa in a French university hospital between 2002 and 2006].
Minchella A; Molinari L; Alonso S; Bouziges N; Sotto A; Lavigne JP
Pathol Biol (Paris); 2010 Feb; 58(1):1-6. PubMed ID: 19875241
[TBL] [Abstract][Full Text] [Related]
37. In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at Forty US Hospitals.
Eagye KJ; Kuti JL; Sutherland CA; Christensen H; Nicolau DP
Clin Ther; 2009 Nov; 31(11):2678-88. PubMed ID: 20110010
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibility profile of Pseudomonas aeruginosa isolates in Egypt.
Gad GF; el-Domany RA; Ashour HM
J Urol; 2008 Jul; 180(1):176-81. PubMed ID: 18499192
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
Manno G; Cruciani M; Romano L; Scapolan S; Mentasti M; Lorini R; Minicucci L
Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511
[TBL] [Abstract][Full Text] [Related]
40. [Antibiotic resistance and biofilm formation in Pseudomonas aeruginosa strains isolated from patients with urinary tract infections].
Cernohorská L; Sláviková P
Epidemiol Mikrobiol Imunol; 2009 Nov; 58(4):154-7. PubMed ID: 21114003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]